Alnylam Pharmaceuticals
ALNY
#868
Rank
S$37.49 B
Marketcap
S$280.20
Share price
-0.17%
Change (1 day)
-49.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company